We found HML-2 expression in the same cells and tissues that expressed stem cell markers, namely OCT4, Nestin, Vimentin, and Sox2 in patients with high-grade glioma (Figure 6 and Supplemental Figure 6A). The gene discussed is VIM; the disease is central nervous system cancer.